{"id":6282,"date":"2014-05-02T13:04:34","date_gmt":"2014-05-02T12:04:34","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=6282"},"modified":"2014-05-02T13:04:34","modified_gmt":"2014-05-02T12:04:34","slug":"un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/","title":{"rendered":"Un resumen sobre la Inmunoterapia en el tratamiento del c\u00e1ncer por el dr. Pedro Gasc\u00f3n"},"content":{"rendered":"<p>\u201cMediante la manipulaci\u00f3n del sistema inmunol\u00f3gico se han logrado respuestas en enfermos que no respond\u00edan a otros tratamientos y no s\u00f3lo en un tipo de tumor\u201d. Son algunas de las declaraciones del dr. Pere Gasc\u00f3n, el conferenciante que invit\u00f3 al Colegio dentro del ciclo Tertulias de actualidad para hablar sobre la Inmunoterapia. Gasc\u00f3n se refiri\u00f3 a los resultados obtenidos a trav\u00e9s de esta terapia como &quot;esperanzadores&quot; (hablo de melanoma, c\u00e1ncer de pulm\u00f3n y c\u00e1ncer renal) aunque &quot;habr\u00e1 que revisar todos los estudios que se est\u00e1n realizando&quot;. Pere Gasc\u00f3n, jefe de Oncolog\u00eda m\u00e9dica del Hospital Cl\u00ednic de Barcelona, habl\u00f3 de &quot;respuestas de hasta un 60% y de un 20-30% de larga duraci\u00f3n&quot;.<\/p>\n<p>En el v\u00eddeo adjunto el dr. Gasc\u00f3n, tambi\u00e9n responsable del Laboratorio de Oncolog\u00eda <a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/05\/cofb.140416-09.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignright  wp-image-6288\" alt=\"C\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/05\/cofb.140416-09.jpg\" width=\"306\" height=\"204\" \/><\/a>Molecular y Transnacional del Hospital Cl\u00ednic, nos define lo que es la inmunoterapia, lo que ha hecho posible esta terapia y lo que se ha descubierto estudiando el entorno del tumor. Tambi\u00e9n destaca que es importante<b> la informaci\u00f3n a los enfermos sobre los f\u00e1rmacos, la pauta de administraci\u00f3n, efectos secundarios, etc. y el papel del farmac\u00e9utico al respecto, as\u00ed como en lo que se refiere a la prevenci\u00f3n del c\u00e1ncer.<\/b><\/p>\n<p>Gasc\u00f3n habl\u00f3 de los linfocitos infiltrantes del tumor (TILs), que han vuelto a recuperar la fama que tuvieron en los a\u00f1os ochenta, de los linfocitos T que expresan unos receptores quimera (CARTs), con resultados positivos en leucemias de adultos y ni\u00f1os, y tambi\u00e9n de los inhibidores de los check points del sistema inmunol\u00f3gico. Todo ello hace que, a su juicio, estemos viviendo \u201cun momento revolucionario y un cambio de paradigma en el tratamiento del c\u00e1ncer\u201d.<\/p>\n<figure id=\"attachment_6290\" aria-describedby=\"caption-attachment-6290\" style=\"width: 510px\" class=\"wp-caption alignright\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/05\/cofb.140416-16.jpg\"><img decoding=\"async\" class=\"wp-image-6290\" alt=\"C\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/05\/cofb.140416-16.jpg\" width=\"510\" height=\"341\" \/><\/a><figcaption id=\"caption-attachment-6290\" class=\"wp-caption-text\">Una vez m\u00e1s, el sal\u00f3n de actos del Colegio se llen\u00f3 de farmac\u00e9uticos para esta Tertulia de actualidad sobre Inmunoterapia (16 de abril). Francisca Aranzana, vocal de Oficina de farmacia, present\u00f3 al conferenciante, el dr. Pedro Gasc\u00f3n.<\/figcaption><\/figure>","protected":false},"excerpt":{"rendered":"<p>\u201cMediante la manipulaci\u00f3n del sistema inmunol\u00f3gico se han logrado respuestas en enfermos que no respond\u00edan a otros tratamientos y no s\u00f3lo en un tipo de tumor\u201d. Son algunas de las declaraciones del dr. Pere Gasc\u00f3n, el conferenciante que invit\u00f3 al Colegio dentro del ciclo Tertulias de actualidad para hablar sobre la [\u2026]<\/p>","protected":false},"author":1,"featured_media":6288,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[70],"class_list":["post-6282","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-formacio"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u201cMitjan\u00e7ant la manipulaci\u00f3 del sistema immunol\u00f2gic s\u2019han aconseguit respostes en malalts que no responien a altres tractaments i no nom\u00e9s en un tipus de tumor\u201d. S\u00f3n algunes de les declaracions del Dr. Pere Gasc\u00f3n, el conferenciant que va convidar el Col\u00b7legi dins del cicle Tert\u00falies d\u2019actualitat per parlar sobre la [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-05-02T12:04:34+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n\",\"datePublished\":\"2014-05-02T12:04:34+00:00\",\"dateModified\":\"2014-05-02T12:04:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/\"},\"wordCount\":372,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Formaci\u00f3\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/\",\"name\":\"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2014-05-02T12:04:34+00:00\",\"dateModified\":\"2014-05-02T12:04:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/","og_locale":"es_ES","og_type":"article","og_title":"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u201cMitjan\u00e7ant la manipulaci\u00f3 del sistema immunol\u00f2gic s\u2019han aconseguit respostes en malalts que no responien a altres tractaments i no nom\u00e9s en un tipus de tumor\u201d. S\u00f3n algunes de les declaracions del Dr. Pere Gasc\u00f3n, el conferenciant que va convidar el Col\u00b7legi dins del cicle Tert\u00falies d\u2019actualitat per parlar sobre la [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2014-05-02T12:04:34+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n","datePublished":"2014-05-02T12:04:34+00:00","dateModified":"2014-05-02T12:04:34+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/"},"wordCount":372,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage"},"thumbnailUrl":"","keywords":["Formaci\u00f3"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/","url":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/","name":"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage"},"thumbnailUrl":"","datePublished":"2014-05-02T12:04:34+00:00","dateModified":"2014-05-02T12:04:34+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2014\/05\/02\/un-resum-sobre-la-immunoterapia-en-el-tractament-del-cancer-pel-dr-pere-gascon\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Un resum sobre la Immunoter\u00e0pia en el tractament del c\u00e0ncer pel Dr. Pere Gasc\u00f3n"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u201cMitjan\u00e7ant la manipulaci\u00f3 del sistema immunol\u00f2gic s\u2019han aconseguit respostes en malalts que no responien a altres tractaments i no nom\u00e9s en un tipus de tumor\u201d. S\u00f3n algunes de les declaracions del Dr. Pere Gasc\u00f3n, el conferenciant que va convidar el Col\u00b7legi dins del cicle Tert\u00falies d\u2019actualitat per parlar sobre la [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/6282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=6282"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/6282\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=6282"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=6282"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=6282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}